Damora Therapeutics Statistics
NASDAQ: DMRAHealth CareBiotechnology: Pharmaceutical PreparationsUSD
23.22-1.08 (-4.44%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Damora Therapeutics by the numbers
Damora Therapeutics has a market capitalization of $1.44 billion based on 61.90M shares outstanding. Its trailing P/E ratio is 13.6, above the 3-company peer median of 7.2. The stock trades 7.0% above its 50-day average and 8.7% below its 200-day average.
Average daily trading volume is 584.28K shares, or about $13.6 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
DMRA valuation vs. peer median
Valuation
- Market cap
- $1.44B
- P/E (TTM)
- 13.58
- EPS (TTM)
- $1.71
- Shares outstanding
- 61.90M
Price and trading
- Previous close
- 24.30
- Open
- 23.81
- Day range
- 23.13 – 24.51
- 52-week range
- 15.76 – 38.33
- 52-week change
- +38.46%
- Beta
- —
- Volume
- 643.38K
- Average volume
- 584.28K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 4, 2026
Additional statistics
- Market Cap
- 1.44B
- Pe
- 13.58
- Forward Pe
- -10.63
- Eps
- 1.71
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 38.33
- Week52 Low
- 15.76
- Avg Volume
- 584.28K
- Shares Outstanding
- 61.90M
- Ma50
- 21.70
- Ma200
- 25.44
- Earnings Date
- Nov 4, 2026
- Pct From52w High
- -39.41%
- Pct From52w Low
- 47.34%